189 related articles for article (PubMed ID: 4309742)
1. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
Mori N; Takemoto J
Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
[No Abstract] [Full Text] [Related]
2. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
Miyatani K; Fukui I
Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
[No Abstract] [Full Text] [Related]
3. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
Landmann H
Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
[No Abstract] [Full Text] [Related]
5. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
Ambrus JL; Schimert G; Lajos TZ; Ambrus CM; Mink IB; Lassman HB; Moore RH; Melzer J
J Med; 1971; 2(2):65-81. PubMed ID: 4329735
[No Abstract] [Full Text] [Related]
6. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
Frick G; Frick U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
[No Abstract] [Full Text] [Related]
7. Studies on the participation of Hageman factor in fibrinolysis.
McDonagh RP; Ferguson JH
Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
[No Abstract] [Full Text] [Related]
8. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
[TBL] [Abstract][Full Text] [Related]
9. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
Moriguchi S
Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
[No Abstract] [Full Text] [Related]
10. [Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator].
Takemoto J
Kumamoto Igakkai Zasshi; 1969 Apr; 43(4):332-59. PubMed ID: 5820070
[No Abstract] [Full Text] [Related]
11. [Antiplasmin and its effect on the process of fibrinolysis in experiments].
Kudriashov BA; Pastorova VE
Biull Eksp Biol Med; 1966 Feb; 61(2):40-2. PubMed ID: 4235805
[No Abstract] [Full Text] [Related]
12. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
Klöcking HP; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
[No Abstract] [Full Text] [Related]
13. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
[No Abstract] [Full Text] [Related]
14. [Inhibitor of fibrinolysis from pancreas pantrypin].
Lakin KM; Efimov VS; Polonskaia LB
Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
[No Abstract] [Full Text] [Related]
15. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
Veremienko KN; Varetskaia TV; Kizim AI; Gerasimenko NG
Ukr Biokhim Zh; 1976; 48(3):337-42. PubMed ID: 134480
[TBL] [Abstract][Full Text] [Related]
16. [Antifibrinolytic agents, a new class of drugs].
Markwardt F
Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
[No Abstract] [Full Text] [Related]
17. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
Lukasiewicz H; Niewiarowski S
Thromb Diath Haemorrh; 1968 Jul; 19(3):584-92. PubMed ID: 4236825
[No Abstract] [Full Text] [Related]
18. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
Geratz JD
Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
[No Abstract] [Full Text] [Related]
19. The biochemistry of the fibrinolytic enzyme system in man.
Rickli EE
Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
[No Abstract] [Full Text] [Related]
20. The effects of some synthetic compounds on in vitro fibrinolytic activity measured by different methods and the relevance to activity in vivo.
Baillie AJ; Sim AK
Thromb Diath Haemorrh; 1972 Dec; 28(3):351-8. PubMed ID: 4265316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
